Why the study?
Clinical trials underrepresent patients at highest risk for cardiovascular disease outcomes, and racial differences in breast cancer treatment-associated CVD mortality had not been explored.
Does the association between breast cancer therapies and CVD mortality differ between non-Hispanic black and non-Hispanic white women?
Does the association between breast cancer therapies and CVD mortality differ between non-Hispanic black and non-Hispanic white women?
Breast cancer therapies, particularly hormone therapy and chemotherapy, may have a more pronounced association with cardiovascular mortality in non-Hispanic black women compared to non-Hispanic white women.
No takes yet. Share an insight, caveat, or question.
May suggest heightened CVD monitoring needs with hormone therapy in non-Hispanic black breast cancer survivors; leaves open confirmation in larger prospective studies.
Collin et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: